QIM
BMRN icon

Quantitative Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quantitative Investment Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,751
Closed -$936K – 393
2025
Q4 		$936K Buy
+15,751
New +$858K 0.09% 216
2024
Q1 		– Sell
-11,565
Closed -$1.11M – 253
2023
Q4 		$1.11M Buy
+11,565
New +$1.02M 0.06% 246
2023
Q1 		– Sell
-23,163
Closed -$2.4M – 232
2022
Q4 		$2.4M Buy
23,163
+18,854
+438% +$1.77M 0.46% 48
2022
Q3 		$365K Buy
+4,309
New +$384K 0.06% 217
2022
Q1 		– Sell
-5,846
Closed -$516K – 209
2021
Q4 		$516K Buy
+5,846
New +$482K 0.07% 175
2021
Q3 		– Sell
-22,070
Closed -$1.84M – 399
2021
Q2 		$1.84M Buy
+22,070
New +$1.75M 0.17% 133
2021
Q1 		– Sell
-25,775
Closed -$2.26M – 507
2020
Q4 		$2.26M Buy
+25,775
New +$2.04M 0.18% 133
2017
Q4 		– Sell
-15,800
Closed -$1.47M – 756
2017
Q3 		$1.47M Buy
15,800
+2,000
+14% +$177K 0.02% 538
2017
Q2 		$1.25M Buy
+13,800
New +$1.26M 0.02% 559
2016
Q2 		– Sell
-28,900
Closed -$2.38M – 749
2016
Q1 		$2.38M Buy
+28,900
New +$2.35M 0.12% 220
2015
Q3 		– Sell
-4,900
Closed -$670K – 686
2015
Q2 		$670K Buy
+4,900
New +$607K 0.1% 186
2015
Q1 		– Sell
-4,900
Closed -$442K – 626
2014
Q4 		$442K Sell
4,900
-1,800
-27% -$150K 0.07% 288
2014
Q3 		$483K Buy
+6,700
New +$440K 0.09% 181
2014
Q2 		– Sell
-50,600
Closed -$3.45M – 470
2014
Q1 		$3.45M Buy
+50,600
New +$3.73M 0.16% 87
2013
Q4 		– Sell
-39,300
Closed -$2.84M – 573
2013
Q3 		$2.84M Buy
+39,300
New +$2.61M 0.25% 78

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantitative Investment Management's BMRN Position: Q1 2026 in Review

Quantitative Investment Management sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2026, closing a stake of 15,751 shares — an estimated $936K sold.

Quantitative Investment Management first reported a position in BMRN in Q3 2013 and held it in 15 quarters. The position peaked at $3.45M in Q1 2014. 559 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

  • Quantitative Investment Management reported no remaining BioMarin Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Quantitative Investment Management sold 15,751 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $936K.
  • Quantitative Investment Management first reported a position in BioMarin Pharmaceuticals in Q3 2013 and held it in 15 quarters.
  • Quantitative Investment Management's BioMarin Pharmaceuticals position peaked at $3.45M in Q1 2014.
  • 559 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on Quantitative Investment Management's 13F filing for Q1 2026, filed 15 May 2026.